Naratriptan Other names: Naratriptan hydrochloride

Chemical formula: C₁₇H₂₅N₃O₂S  Molecular mass: 335.464 g/mol  PubChem compound: 4440

Therapeutic indications

Naratriptan is indicated for:

Migraine attacks with or without aura

Population group: only adults (18 - 65 years old)

Naratriptan is indicated for the acute treatment of migraine attacks with or without aura.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Naratriptan is contraindicated in the following cases:

Myocardial infarction, ischaemic heart disease, Prinzmetal's angina, coronary vasospasm, peripheral vascular disease

at least one of
Myocardial infarction
Ischemic heart disease
Prinzmetal angina
Silent coronary vasospastic disease
Peripheral vascular disease

Cerebrovascular accident (CVA), transient ischaemic attack (TIA)

at least one of
CVA - Cerebrovascular accident
H/O: CVA
Temporary cerebral vascular dysfunction
History of transient ischemic attack

Hypertension

Hypertension

Ergotamine, derivatives of ergotamine, selective serotonin (5-HT₁) agonists

at least one of
Ergot alkaloids
Selective serotonin (5HT1) agonists

Severely impaired renal function (creatinine clearance <15 ml/min)

Renal failure stage 5: Kidney failure (GFR <15 mL/min/1.73 m2 or dialysis)

Severely impaired hepatic function (Child-Pugh grade C)

Hepatic failure stage IV

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2019: NARAMIG Tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈